The presence of at least three out of five criteria (AFP > 1000 ng/dL, Venous expansion, thrombus Enhancement, Neovascularity, and Adjacent to HCC) had 100% sensitivity and 94% specificity in the diagnosis of tumour portal vein thrombosis [75]. This evidence concerns the gene AFP and neoplasm.